The Michael J. Fox Foundation is extending its support of Clemson
professor, Xuejun Wen, whose research focuses on the use of human
stem cells in finding a cure for Parkinson ’s disease. The
illness currently affects 1 million people in the United States,
and that number increases by 50,000 every year. Wen is a professor
of bioengineering, cell biology and anatomy at Clemson, but works
at the Medical University of South Carolina through the CU-MUSC
Bioengineering Program.

The use of human stem cells to supply specialized cells to repair
the body is one aspect of regenerative medicine, a branch of bioengineering
that uses knowledge of how cells form, specialize and organize to
repair or replace damaged tissue and organs. Clemson, MUSC and the
University of South Carolina have formed a biomedical engineering
partnership that could make South Carolina a leader in regenerative
medicine and bioengineering technology.

Xuejun Wen, professor of bioengineering,
cell biology, and anatomy at Clemson, works at the Medical University
of South Carolina through the CU-MUSC Bioengineering Program. His
research focuses on using human stem cells to cure Parkinson’s
disease.

Earnest is published by the College
of Engineering and Science at Clemson University for the alumni
and friends of the College. Subscriptions are free upon request.